source
- Epic's AI push overlaps with health tech startupsVERONA, WI — Epic showed off its continued expansion of AI for clinicians and patients at its annual Users Group Meeting on Tuesday, putting pressure on startups across the health tech industry. Dr…Endpoints · 3h ago↗ source
- Merck’s Moderna-partnered vaccine success clears view of post-Keytruda futureInvestors had been pessimistic about the probability of success for the personalized cancer vaccine intismeran autogene, so the Phase 3 win was a welcome surprise.BioSpace · 4h ago↗ source
- FDA approves Regeneron’s garetosmab for ultra-rare bone-forming diseaseThe FDA has granted approval to Regeneron's antibody garetosmab, which targets activin A, for the treatment of fibrodysplasia ossificans progressiva (FOP). FOP is an ultra‑rare disorder that causes…